Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 402-070-1 | CAS number: 88122-99-0 UVINUL T 150
Endpoint summary
Administrative data
Description of key information
NOEL=1 000 mg/kg bw/day (nominal)
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- yes
- Limit test:
- no
- Species:
- rat
- Route of administration:
- oral: unspecified
- Vehicle:
- other: Rat/ Mouse and haster diet 343
- Details on oral exposure:
- Method of administration: in the diet
- Duration of treatment / exposure:
- Test duration: 90 days
- Frequency of treatment:
- Dosing regime: 7 days/week
- No. of animals per sex per dose:
- Male: 10 animals at 0 mg/kg bw/day
Male: 10 animals at 1000 mg/kg bw/day
Male: 10 animals at 4000 mg/kg bw/day
Male: 10 animals at 16000 mg/kg bw/day
Female: 10 animals at 0 mg/kg bw/day
Female: 10 animals at 1000 mg/kg bw/day
Female: 10 animals at 4000 mg/kg bw/day
Female: 10 animals at 16000 mg/kg bw/day - Details on results:
- Clinical observations: o.B., no abnormalities noted
Laboratory findings: findings were not considered to be treatment related
Effects in organs: no treatment related effects - Dose descriptor:
- NOAEL
- Effect level:
- <= 1 275 mg/kg bw/day (nominal)
- Basis for effect level:
- other: original NCD unit is mg/kg/day.
- Remarks on result:
- other: not further specified
- Critical effects observed:
- not specified
- Conclusions:
- Classified as: Not classified
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 408 (1987)
- GLP compliance:
- yes
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- not specified
- Route of administration:
- oral: unspecified
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Method of administration : food
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Test duration : 90 days
- Frequency of treatment:
- Dosing regime : 7 days/week
- Details on results:
- Clinical observations : No premature mortalities occurred. Clinically, laboratory-diagnostically and
pathomorphologically, no substance related pathological changes could be observed.
Laboratory findings : Slight variations in the haematological and clinico-chemical parameters co
rresponded to the range of biological variaton in the species.
Effects in organs : Liver weight increases without histological correlates among treated female a
nimals could not be interpreted as being substance related. - Dose descriptor:
- NOEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Sex:
- not specified
- Basis for effect level:
- other:
- Remarks on result:
- other: not further specified
- Critical effects observed:
- not specified
- Conclusions:
- not classified
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 275 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
